My issue with the subjective reporting of pain as being a primary end point is that there are a lot of reasons people are motivated to lie about their level of back pain. Compensation claims which depend on on-going pain - or drug addicts that purport to be in pain to continue obtaining opioid medications.
For me the key outcome is the 40% reduction in opioid use in the treated cohort, this is hard to look past.
Sentiment changed to buy and we'll see if I change to Hold after the opening auction.
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-53
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |